Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Franssen (Maastricht, Netherlands). What data should be collected during severe exacerbations?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC

Member's Comments

No comment yet.

Related content which might interest you: Heterogeneity and time course of asthma exacerbations: data from AUSTRI Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis Source: Eur Respir J, 54 (5) 1901381; 10.1183/13993003.01381-2019 Year: 2019 Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 A typical COPD exacerbation? Source: Breathe 2008; 4: 346-354 Year: 2008 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Blood eosinophilia(BE) and outcomes in patients with acute severe exacerbations of COPD(AECOPD) Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020 Year: 2021 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016